FP7H2020HORIZON
Istituto Ortopedico Rizzoli
- Country
- ITItaly
- Defence projects
- 0
- Projects, all programmes
- 33
- As coordinator
- 4
- EU contribution (CORDIS)
- EUR 10,869,099
- Active
- 2008 to 2025
Projects
33 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| MEASURINGMultiparametric Evaluation of osteosarcopeniA diSease Using magnetic Resonance ImagiNG | HORIZON | 2025 | Associated partner | EUR 0 |
| ERDERAEUROPEAN RARE DISEASES RESEARCH ALLIANCE | HORIZON | 2024 | Participant | EUR 16,250 |
| METASTRACOMPUTER-AIDED EFFECTIVE FRACTURE RISK STRATIFICATION OF PATIENTS WITH VERTEBRAL METASTASES FOR PERSONALISED TREATMENT THROUGH ROBUST COMPUTATIONAL MODELS VALIDATED IN CLINICAL SETTINGS | HORIZON | 2023 | Participant | EUR 481,750 |
| DIALECTDiabetes Lower Extremity Complications Research and Training Network in Foot Ulcer and Amputation Prevention | HORIZON | 2022 | Associated partner | EUR 0 |
| REMEDi4ALLBUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL | HORIZON | 2022 | Participant | EUR 631,725 |
| ISWIn Silico World: Lowering barriers to ubiquitous adoption of In Silico Trials | H2020 | 2021 | Third party | Not stated |
| ADMAIORAADvanced nanocomposite MAterIals fOr in situ treatment and ultRAsound-mediated management of osteoarthritis | H2020 | 2019 | Participant | EUR 1,285,375 |
| SELNETSarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network | H2020 | 2019 | Participant | EUR 432,000 |
| FURTHERFocused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients with Bone Metastasis | H2020 | 2019 | Participant | EUR 379,059 |
| EJP RDEuropean Joint Programme on Rare Diseases | H2020 | 2019 | Participant | EUR 93,215 |
| ITCC-P4ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | H2020 | 2017 | Third party | Not stated |
| ORTHOUNIONORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft in long bone nonUNIONs | H2020 | 2017 | Participant | EUR 449,923 |
| MCDS-TherapyRepurposing of carbamazepine for treatment of skeletal dysplasia | H2020 | 2017 | Participant | EUR 857,175 |
| DeTOPDexterous Transradial Osseointegrated Prosthesis with neural control and sensory feedback | H2020 | 2016 | Participant | EUR 15,800 |
| ADIPOA2Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis | H2020 | 2015 | Participant | EUR 354,600 |
| ADOPT BBMRI-ERICimplementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC | H2020 | 2015 | Participant | EUR 103,530 |
| CORBELCoordinated Research Infrastructures Building Enduring Life-science services | H2020 | 2015 | Third party | Not stated |
| CloudSMECloud based Simulation platform for Manufacturing and Engineering | FP7 | 2013 | Participant | EUR 18,911 |
| EECEURO EWING Consortium – International Clinical Trials to Improve Survival from Ewing Sarcoma | FP7 | 2013 | Participant | EUR 294,718 |
| EUROSARCEuropean Clinical trials in Rare Sarcomas within an integrated translational trial network | FP7 | 2011 | Participant | EUR 278,643 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.